ZNF593
gene geneOn this page
Also known as ZT86
Summary
ZNF593 (zinc finger protein 593, HGNC:30943) is a protein-coding gene on chromosome 1p36.11, encoding Zinc finger protein 593 (O00488). Involved in pre-60S ribosomal particles maturation by promoting the nuclear export of the 60S ribosome. It is a selective cancer dependency (DepMap: 26.8% of cell lines).
Enables preribosome binding activity and zinc ion binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm.
Source: NCBI Gene 51042 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 18 total
- Cancer dependency (DepMap): dependent in 26.8% of screened cell lines
- MANE Select transcript:
NM_015871
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30943 |
| Approved symbol | ZNF593 |
| Name | zinc finger protein 593 |
| Location | 1p36.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZT86 |
| Ensembl gene | ENSG00000142684 |
| Ensembl biotype | protein_coding |
| OMIM | 616698 |
| Entrez | 51042 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000270812, ENST00000374266
RefSeq mRNA: 1 — MANE Select: NM_015871
NM_015871
CCDS: CCDS275
Canonical transcript exons
ENST00000374266 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000955850 | 26170418 | 26170480 |
| ENSE00000955851 | 26170575 | 26170873 |
| ENSE00001562469 | 26169908 | 26170183 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 94.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 73.8449 / max 460.4157, expressed in 1815 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1561 | 72.2132 | 1815 |
| 1562 | 1.6316 | 934 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 94.96 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 94.11 | gold quality |
| muscle of leg | UBERON:0001383 | 93.76 | gold quality |
| body of pancreas | UBERON:0001150 | 93.68 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.35 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 91.85 | gold quality |
| muscle organ | UBERON:0001630 | 91.83 | gold quality |
| body of stomach | UBERON:0001161 | 91.58 | gold quality |
| gluteal muscle | UBERON:0002000 | 91.29 | gold quality |
| apex of heart | UBERON:0002098 | 91.22 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.12 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 91.11 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.81 | gold quality |
| oocyte | CL:0000023 | 89.74 | gold quality |
| peritoneum | UBERON:0002358 | 89.48 | gold quality |
| omental fat pad | UBERON:0010414 | 89.48 | gold quality |
| left adrenal gland | UBERON:0001234 | 89.15 | gold quality |
| right atrium auricular region | UBERON:0006631 | 89.05 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 88.95 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 88.82 | gold quality |
| heart left ventricle | UBERON:0002084 | 88.72 | gold quality |
| left uterine tube | UBERON:0001303 | 88.68 | gold quality |
| pancreas | UBERON:0001264 | 88.58 | gold quality |
| adenohypophysis | UBERON:0002196 | 88.56 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 88.55 | gold quality |
| right adrenal gland | UBERON:0001233 | 88.52 | gold quality |
| left coronary artery | UBERON:0001626 | 88.46 | gold quality |
| skin of abdomen | UBERON:0001416 | 88.40 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 88.38 | gold quality |
| cardiac ventricle | UBERON:0002082 | 88.26 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-75367 | no | 166.68 |
| E-HCAD-5 | no | 2.25 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting ZNF593, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-9851-3P | 99.63 | 69.68 | 1110 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-593-5P | 99.34 | 69.50 | 965 |
| HSA-MIR-3173-5P | 97.35 | 65.82 | 1282 |
| HSA-MIR-6799-3P | 97.35 | 65.60 | 1302 |
| HSA-MIR-6760-3P | 96.35 | 68.31 | 1001 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 26.8% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- The tertiary structure of the zinc finger domain of ZNF593 is composed of a beta-hairpin that positions the cysteine side chains for zinc coordination, followed by an atypical kinked alpha-helix containing the two histidine side chain ligands. (PMID:18287285)
- LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy. (PMID:33550812)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf593 | ENSDARG00000044102 |
| mus_musculus | Zfp593 | ENSMUSG00000028840 |
| rattus_norvegicus | Zfp593 | ENSRNOG00000016392 |
| drosophila_melanogaster | CG3224 | FBGN0029885 |
| caenorhabditis_elegans | WBGENE00013236 |
Paralogs (1): NDUFAB1 (ENSG00000004779)
Protein
Protein identifiers
Zinc finger protein 593 — O00488 (reviewed: O00488)
Alternative names: Zinc finger protein T86
All UniProt accessions (2): O00488, A9J4F5
UniProt curated annotations — full annotation on UniProt →
Function. Involved in pre-60S ribosomal particles maturation by promoting the nuclear export of the 60S ribosome. Negatively modulates the DNA binding activity of Oct-2 and therefore its transcriptional regulatory activity.
Subunit / interactions. Associates with pre-60S ribosomal particles.
Subcellular location. Nucleus. Nucleolus. Cytoplasm.
Tissue specificity. Ubiquitous. Detected in spleen, prostate, testis, small intestine, colon and to a minor level in thymus and peripheral blood leukocytes.
Domain organisation. The protein is largely disordered, with the exception of the zinc finger domain.
Similarity. Belongs to the ZNF593/BUD20 C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_056955* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003604 | Matrin/U1-like-C_Znf_C2H2 | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR022755 | Znf_C2H2_jaz | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR051879 | C2H2-ZF_Maturation_Protein | Family |
Pfam: PF12171
UniProt features (13 total): helix 3, turn 2, region of interest 2, compositionally biased region 2, chain 1, zinc finger region 1, sequence variant 1, strand 1
Structure
Experimental structures (PDB)
26 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8FLE | ELECTRON MICROSCOPY | 2.48 |
| 8FL3 | ELECTRON MICROSCOPY | 2.53 |
| 8FL7 | ELECTRON MICROSCOPY | 2.55 |
| 8FLB | ELECTRON MICROSCOPY | 2.55 |
| 8FLD | ELECTRON MICROSCOPY | 2.58 |
| 8FL6 | ELECTRON MICROSCOPY | 2.62 |
| 8FLA | ELECTRON MICROSCOPY | 2.63 |
| 8FLF | ELECTRON MICROSCOPY | 2.65 |
| 8FL2 | ELECTRON MICROSCOPY | 2.67 |
| 8FL9 | ELECTRON MICROSCOPY | 2.75 |
| 8FLC | ELECTRON MICROSCOPY | 2.76 |
| 8IDT | ELECTRON MICROSCOPY | 2.8 |
| 8RL2 | ELECTRON MICROSCOPY | 2.84 |
| 8FL4 | ELECTRON MICROSCOPY | 2.89 |
| 8IDY | ELECTRON MICROSCOPY | 3 |
| 8INF | ELECTRON MICROSCOPY | 3 |
| 6LU8 | ELECTRON MICROSCOPY | 3.13 |
| 8INE | ELECTRON MICROSCOPY | 3.2 |
| 8INK | ELECTRON MICROSCOPY | 3.2 |
| 8IPD | ELECTRON MICROSCOPY | 3.2 |
| 8IPY | ELECTRON MICROSCOPY | 3.2 |
| 6LSS | ELECTRON MICROSCOPY | 3.23 |
| 8IE3 | ELECTRON MICROSCOPY | 3.3 |
| 8IR3 | ELECTRON MICROSCOPY | 3.5 |
| 8IPX | ELECTRON MICROSCOPY | 4.3 |
| 1ZR9 | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O00488-F1 | 77.25 | 0.21 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 163 (showing top):
ATF_B, CREL_01, GOBP_RIBOSOME_BIOGENESIS, PAX4_01, BASSO_B_LYMPHOCYTE_NETWORK, ENK_UV_RESPONSE_KERATINOCYTE_UP, GCANCTGNY_MYOD_Q6, SHEPARD_CRASH_AND_BURN_MUTANT_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, AREB6_01, BROWNE_HCMV_INFECTION_16HR_UP, GGGTGGRR_PAX4_03, CAGCTG_AP4_Q5, NFKB_Q6, CREB_Q4
GO Biological Process (3): ribosome biogenesis (GO:0042254), positive regulation of transcription by RNA polymerase II (GO:0045944), negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)
GO Molecular Function (7): DNA binding (GO:0003677), zinc ion binding (GO:0008270), preribosome binding (GO:1990275), nucleic acid binding (GO:0003676), protein binding (GO:0005515), ribonucleoprotein complex binding (GO:0043021), metal ion binding (GO:0046872)
GO Cellular Component (4): nucleoplasm (GO:0005654), nucleolus (GO:0005730), cytoplasm (GO:0005737), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| nuclear lumen | 2 |
| cellular anatomical structure | 2 |
| ribonucleoprotein complex biogenesis | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| positive regulation of DNA-templated transcription | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| regulation of RNA polymerase II regulatory region sequence-specific DNA binding | 1 |
| negative regulation of transcription regulatory region DNA binding | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| ribonucleoprotein complex binding | 1 |
| protein-containing complex binding | 1 |
| cation binding | 1 |
| intracellular membraneless organelle | 1 |
| intracellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
2368 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF593 | ZNF622 | Q969S3 | 483 |
| ZNF593 | GNL2 | Q13823 | 478 |
| ZNF593 | RSL24D1 | Q9UHA3 | 474 |
| ZNF593 | DDX27 | Q96GQ7 | 472 |
| ZNF593 | LSG1 | Q9H089 | 466 |
| ZNF593 | NOP16 | Q9Y3C1 | 462 |
| ZNF593 | MRTO4 | Q9UKD2 | 461 |
| ZNF593 | NMD3 | Q96D46 | 456 |
| ZNF593 | CCDC9 | Q9Y3X0 | 443 |
| ZNF593 | SUOX | P51687 | 433 |
| ZNF593 | DALRD3 | Q5D0E6 | 431 |
| ZNF593 | LLPH | Q9BRT6 | 424 |
| ZNF593 | EIF6 | P56537 | 424 |
| ZNF593 | PA2G4 | Q9UQ80 | 421 |
| ZNF593 | TIMM44 | O43615 | 419 |
IntAct
50 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| NEUROG3 | GXYLT2 | psi-mi:“MI:0914”(association) | 0.640 |
| LNX1 | ZNF593 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF593 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF593 | DDIT4L | psi-mi:“MI:0915”(physical association) | 0.560 |
| FGF3 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MECP2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF512 | ZNF724 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF689 | ZNF593 | psi-mi:“MI:0914”(association) | 0.530 |
| LUC7L2 | ZNF593 | psi-mi:“MI:0914”(association) | 0.530 |
| CGAS | ZNF593 | psi-mi:“MI:0915”(physical association) | 0.400 |
| POLR1H | ZNF593 | psi-mi:“MI:0915”(physical association) | 0.370 |
| GPR3 | ZNF593 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF593 | MAP3K7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAPK8IP2 | ZNF593 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MAP3K20 | ZNF593 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CLEC3A | ZNF593 | psi-mi:“MI:0914”(association) | 0.350 |
| PRR20E | ZNF593 | psi-mi:“MI:0914”(association) | 0.350 |
| CCDC60 | ZNF593 | psi-mi:“MI:0914”(association) | 0.350 |
| ARRDC3 | ZNF593 | psi-mi:“MI:0914”(association) | 0.350 |
| CHCHD10 | ZNF593 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC16A11 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| BMI1 | HMGB1P1 | psi-mi:“MI:0914”(association) | 0.350 |
| BMI1 | MEIS3P1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (65): LNX1 (Two-hybrid), ZNF593 (Co-fractionation), ZNF593 (Biochemical Activity), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS), ZNF593 (Affinity Capture-MS)
ESM2 similar proteins: A2XIP9, A4IIB1, A5D7C2, A5DFT1, A5DYR5, B0BLT0, O00488, O42832, P25582, P34670, P38344, P41900, Q08004, Q09776, Q2VPG3, Q32LB0, Q3TWF6, Q4SQ06, Q4WVH3, Q54N72, Q553S1, Q5BH88, Q5EB92, Q5RJT2, Q5XIQ5, Q5ZKM1, Q6BNQ8, Q6BWR0, Q6C9Q1, Q6CV12, Q6DD06, Q6DGI3, Q6FX63, Q6GPP0, Q6NV26, Q751U1, Q75LU5, Q80UZ2, Q8SWF6, Q96NC0
Diamond homologs: B0BLT0, O00488, Q08004, Q553S1, Q8SWF6, Q9DB42, Q9P370, Q9U239, Q9W3Y0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
508 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:26170180:GCGC:G | donor_gain | 1.0000 |
| 1:26170182:GC:G | donor_gain | 1.0000 |
| 1:26170184:G:GG | donor_gain | 1.0000 |
| 1:26170416:A:AG | acceptor_gain | 1.0000 |
| 1:26170416:AG:A | acceptor_gain | 1.0000 |
| 1:26170417:G:GG | acceptor_gain | 1.0000 |
| 1:26170417:GG:G | acceptor_gain | 1.0000 |
| 1:26170417:GGA:G | acceptor_gain | 1.0000 |
| 1:26170481:G:GA | donor_loss | 1.0000 |
| 1:26170488:GGA:G | donor_gain | 1.0000 |
| 1:26170489:GAG:G | donor_gain | 1.0000 |
| 1:26170573:A:AG | acceptor_gain | 1.0000 |
| 1:26170574:G:GG | acceptor_gain | 1.0000 |
| 1:26170574:GGCT:G | acceptor_gain | 1.0000 |
| 1:26170099:G:T | donor_gain | 0.9900 |
| 1:26170181:CGCG:C | donor_loss | 0.9900 |
| 1:26170183:CG:C | donor_loss | 0.9900 |
| 1:26170184:G:A | donor_loss | 0.9900 |
| 1:26170185:TGA:T | donor_loss | 0.9900 |
| 1:26170186:G:GC | donor_loss | 0.9900 |
| 1:26170187:A:AC | donor_loss | 0.9900 |
| 1:26170188:G:C | donor_loss | 0.9900 |
| 1:26170194:G:GT | donor_gain | 0.9900 |
| 1:26170262:G:GT | donor_gain | 0.9900 |
| 1:26170408:A:AG | acceptor_gain | 0.9900 |
| 1:26170416:AGGAG:A | acceptor_gain | 0.9900 |
| 1:26170417:GGAGG:G | acceptor_gain | 0.9900 |
| 1:26170481:G:GG | donor_gain | 0.9900 |
| 1:26170491:G:GG | donor_gain | 0.9900 |
| 1:26170573:A:AT | acceptor_loss | 0.9900 |
AlphaMissense
855 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:26170475:G:C | K86N | 0.993 |
| 1:26170475:G:T | K86N | 0.993 |
| 1:26170615:G:C | A102P | 0.992 |
| 1:26170452:C:G | H79D | 0.991 |
| 1:26170454:C:A | H79Q | 0.990 |
| 1:26170454:C:G | H79Q | 0.990 |
| 1:26170470:C:G | H85D | 0.989 |
| 1:26170472:C:A | H85Q | 0.986 |
| 1:26170472:C:G | H85Q | 0.986 |
| 1:26170170:T:C | C63R | 0.985 |
| 1:26170465:A:T | K83I | 0.983 |
| 1:26170452:C:A | H79N | 0.982 |
| 1:26170180:G:A | C66Y | 0.981 |
| 1:26170466:A:C | K83N | 0.981 |
| 1:26170466:A:T | K83N | 0.981 |
| 1:26170170:T:A | C63S | 0.980 |
| 1:26170171:G:C | C63S | 0.980 |
| 1:26170425:T:C | F70L | 0.980 |
| 1:26170427:C:A | F70L | 0.980 |
| 1:26170427:C:G | F70L | 0.980 |
| 1:26170461:T:C | S82P | 0.978 |
| 1:26170586:T:C | L92P | 0.977 |
| 1:26170179:T:C | C66R | 0.976 |
| 1:26170577:T:C | L89P | 0.976 |
| 1:26170179:T:A | C66S | 0.975 |
| 1:26170180:G:C | C66S | 0.975 |
| 1:26170470:C:A | H85N | 0.975 |
| 1:26170181:C:G | C66W | 0.972 |
| 1:26170627:G:C | A106P | 0.972 |
| 1:26170153:G:A | G57E | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000438754 (1:26169162 A>G), RS1001791870 (1:26168450 A>G), RS1003442049 (1:26170564 C>G), RS1005264087 (1:26169280 G>A), RS1005788142 (1:26169589 C>T), RS1008137840 (1:26170992 C>T), RS1008168906 (1:26171192 C>A,G,T), RS1008744371 (1:26167920 G>A), RS1009180798 (1:26169885 C>A,G), RS1009205661 (1:26170084 A>G), RS1011629816 (1:26170538 C>T), RS1012707331 (1:26168784 T>C), RS1014021399 (1:26167970 G>C), RS1015468593 (1:26169297 C>T), RS1017017858 (1:26170521 G>A)
Disease associations
OMIM: gene MIM:616698 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression, decreases reaction, increases abundance | 2 |
| Benzo(a)pyrene | affects methylation, increases expression | 2 |
| Nickel | increases expression | 2 |
| Valproic Acid | decreases methylation, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| ginger extract | decreases reaction, increases abundance, decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| butyraldehyde | increases expression | 1 |
| cylindrospermopsin | increases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants, Occupational | affects expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Catechin | increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Flavonoids | increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Oils, Volatile | decreases reaction, increases abundance, decreases expression | 1 |
| Phenobarbital | affects expression | 1 |
| Plant Extracts | increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3LM | Abcam HEK293T ZNF593 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.